Detalles de la búsqueda
1.
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
BMC Cancer
; 18(1): 98, 2018 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29370781
2.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 22(12): 1463-1469, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860412
3.
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Gastric Cancer
; 20(5): 825-833, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028664
4.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 23(2): 272, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449512
5.
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment.
Breast
; 30: 151-155, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27750105
6.
Angiogenic inhibitors for older patients with advanced colorectal cancer: does the age hold the stage?
World J Gastroenterol
; 19(14): 2131-40, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23847406
Resultados
1 -
6
de 6
1
Próxima >
>>